Record Information |
---|
Version | 1.0 |
---|
Created at | 2020-12-09 02:18:00 UTC |
---|
Updated at | 2021-07-15 16:50:29 UTC |
---|
NP-MRD ID | NP0004900 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | (Z)-lowdenic acid |
---|
Provided By | NPAtlas![NPAtlas Logo](/attributions/npatlas_logo_square_small.png) |
---|
Description | (Z)-lowdenic acid is found in Verticillium. It was first documented in 2003 (PMID: 14510612). Based on a literature review very few articles have been published on 2-[(2S)-4-[(2Z,5R)-5-methyl-5-[(4S)-4-methyltetradecyl]-2,5-dihydrofuran-2-ylidene]-3,5-dioxooxolan-2-yl]acetic acid (PMID: 34380192) (PMID: 34380191) (PMID: 34380190) (PMID: 34380189). |
---|
Structure | [H]OC(=O)C([H])([H])[C@]1([H])OC(=O)\C(=C2/O[C@](C([H])=C2[H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C1=O InChI=1S/C26H40O6/c1-4-5-6-7-8-9-10-11-13-19(2)14-12-16-26(3)17-15-20(32-26)23-24(29)21(18-22(27)28)31-25(23)30/h15,17,19,21H,4-14,16,18H2,1-3H3,(H,27,28)/b23-20-/t19-,21-,26+/m0/s1 |
---|
Synonyms | Value | Source |
---|
2-[(2S)-4-[(2Z,5R)-5-Methyl-5-[(4S)-4-methyltetradecyl]-2,5-dihydrofuran-2-ylidene]-3,5-dioxooxolan-2-yl]acetate | Generator | (Z)-Lowdenate | Generator |
|
---|
Chemical Formula | C26H40O6 |
---|
Average Mass | 448.6000 Da |
---|
Monoisotopic Mass | 448.28249 Da |
---|
IUPAC Name | 2-[(2S)-4-[(2Z,5R)-5-methyl-5-[(4S)-4-methyltetradecyl]-2,5-dihydrofuran-2-ylidene]-3,5-dioxooxolan-2-yl]acetic acid |
---|
Traditional Name | [(2S)-4-[(2Z,5R)-5-methyl-5-[(4S)-4-methyltetradecyl]furan-2-ylidene]-3,5-dioxooxolan-2-yl]acetic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCCCCCCCC[C@H](C)CCC[C@@]1(C)O\C(C=C1)=C1/C(=O)O[C@@H](CC(O)=O)C1=O |
---|
InChI Identifier | InChI=1S/C26H40O6/c1-4-5-6-7-8-9-10-11-13-19(2)14-12-16-26(3)17-15-20(32-26)23-24(29)21(18-22(27)28)31-25(23)30/h15,17,19,21H,4-14,16,18H2,1-3H3,(H,27,28)/b23-20-/t19-,21-,26+/m0/s1 |
---|
InChI Key | GTHQWTZYJQZCCN-QOZNHZNQSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Angawi RF, Swenson DC, Gloer JB, Wicklow DT: Lowdenic acid: a new antifungal polyketide-derived metabolite from a new fungicolous Verticillium sp. J Nat Prod. 2003 Sep;66(9):1259-62. doi: 10.1021/np0301285. [PubMed:14510612 ]
- Kim S, Park KY, Chung J, Kim YB, Lee JW, Huh SK: Comparative Analysis of Feasibility of the Retrograde Suction Decompression Technique for Microsurgical Treatment of Large and Giant Internal Carotid Artery Aneurysms. J Korean Neurosurg Soc. 2021 Aug 12. pii: jkns.2021.0066. doi: 10.3340/jkns.2021.0066. [PubMed:34380192 ]
- Bahloul M, Kharrat S, Chtara K, Hafdhi M, Turki O, Baccouche N, Ammar R, Kallel N, Hsairi M, Chakroun-Walha O, Hamida CB, Chelly H, Mahfoudh KB, Karoui A, Karray H, Rekik N, Bouaziz M: Clinical characteristics and outcomes of critically ill COVID-19 patients in Sfax, Tunisia. Acute Crit Care. 2021 Aug 12. pii: acc.2021.00129. doi: 10.4266/acc.2021.00129. [PubMed:34380191 ]
- Yi J, Kim KH: Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units. Acute Crit Care. 2021 Aug 12. pii: acc.2021.00409. doi: 10.4266/acc.2021.00409. [PubMed:34380190 ]
- Lee Y, Kim SH, Hwang HY, Sohn SH, Choi JW, Kim KH: Perfusion parameters during cardiopulmonary bypass as a predictor of acute kidney injury after aortic valve replacement. Acute Crit Care. 2021 Aug 12. pii: acc.2021.00094. doi: 10.4266/acc.2021.00094. [PubMed:34380189 ]
|
---|